For the first time in Uzbekistan’s history, a complex surgical operation was performed to reconstruct the pelvic ring with an individual endoprosthesis at the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, together with a leading Russian oncologist.
The operation took place within the framework of a memorandum of cooperation between the Association of Oncologists of Uzbekistan (AOUz) and the East-European Sarcoma Group. The purpose of the memorandum is to expand the geography of scientific and practical cooperation in the field of oncology, as well as to facilitate the exchange of information, experience and professional skills in the joint development of new methods and techniques for diagnosis and treatment in the oncological service.
Tumors of the pelvic bones are a relatively rare localization of bone tumors. Despite the advances in modern oncology and surgery, the treatment and diagnosis of pelvic bone tumors remain challenging in clinical oncology. This pathology most often occurs in the working age and has previously led to the performance of mutilation and permanent disability of patients.
Now, according to the Center of Oncology and Radiology, approaches to the surgical treatment of tumors of the pelvic bones involve, along with the removal of the tumor, the performance of reconstructive plastic operations.
The development of computer and 3D technologies in medicine and technology made it possible to make a breakthrough in the creation of individual prosthetics systems, including those based on 3D printing of titanium alloys, which makes it possible to perform organ-preserving surgeries, reduce the incidence of complications, accelerate rehabilitation and improve the quality of life of patients with tumor lesions of pelvic bones.
A unique operation for Uzbekistan was performed on October 11 by the head of the department of tumors of the musculoskeletal system, Jamila Pulatova, together with a Russian colleague - the head of the Moscow City Scientific and Practical Center for Tumors of Bones, Soft Tissues and Skin at Moscow Cancer Hospital No. 62, Professor Elmar Musaev.